Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer
Status:
Completed
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
This study will evaluate serum vitamin D (25(OH)D) and serum leptin levels at the time of
diagnosis of ovarian, primary peritoneal, and/or fallopian tube cancer as well as vitamin D
receptor mutation status (FokI SNP genotype). The study will evaluate the impact of vitamin D
repletion on serum vitamin D levels, serum leptin levels, and treatment-related morbidity in
these patients.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Oklahoma
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins